Litcius/Paper detail

Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC

Joe Y. Chang, Vivek Verma, James W. Welsh, Silvia C. Formenti

2022The Lancet Oncology12 citationsDOI

Topics & Concepts

BlockadeImmune checkpointOncologyMedicinePD-L1non-small cell lung cancer (NSCLC)Internal medicineRadiation therapyCancer researchImmunotherapyReceptorCancerLung cancerA549 cellCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsFerroptosis and cancer prognosis